Dr.Prasanna venkataraman
AIM: To study the safety and efficacy of aurolab aqueous drainage implant (AADI) 250 in childhood glaucoma.
METHODS: A retrospective study of patients with childhood glaucoma who underwent AADI 250 between Jan 2015 and Dec2016. Primary outcome measures were intraocular pressure (IOP), the need for antiglaucoma medications (AGM) after surgery and complications.
RESULTS: Nine eyes of 6 patients were included with a mean (±SD) age of 8.7 ±1.7 years and follow-up of 9.3±3.4 months. Mean IOP reduced from 27.2±4.5 to 12.9±7.4 mm Hg at 6months and 15.3±2.4 mm Hg at 1 year (p = 0.003). Mean number of AGM reduced from 3.7 to 0.5 at 6months and 0.67 at1 year (p = 0.027). There was no tube erosion or infection or loss of light perception.
CONCLUSION: Aurolab Aqueous Drainage Implant -250 mm2 appears to be safe and efficacious as other drainage implants in childhood glaucoma.
Leave a Comment